Skip to main content
Deciphera
Deciphera Medical Affairs
  • Our Company
    • Who We Are
    • Leadership
  • Focus Areas
    • Overview
    • Oncology
    • Immunology & Inflammation
    • Neurology
  • Pipeline
    • Ongoing Clinical Trials
    • Presentations & Publications
  • Patients & Care Partners
    • Expanded Access
  • Healthcare Professionals (Coming soon!)
  • Our Medicines
  • Join Us
    • Our Culture
    • Open Positions
  • News
  • Ono Pharma

Sapablursen

A Study to Evaluate Sapablursen (Formerly ISIS 702843, IONIS-TMPRSS6-LRx) in Patients With Polycythemia Vera (NCT05143957)
  • Oncology
  • Disease/Condition: Polycythemia Vera (PV)
A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV) (INTREPID) (NCT07429266)
  • Oncology
  • Disease/Condition: Polycythemia Vera (PV)

© 2026 Deciphera Pharmaceuticals, LLC. Deciphera Pharmaceuticals, LLC, DECIPHERA, and the Deciphera logo are registered trademarks of Deciphera Pharmaceuticals.

  • Privacy Policy
  • Contact Us
  • Terms of Use
linkedin twitter
DCPH-M01057 v1 09/26
Back to top